Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202

Authors

M. Mody
N. Dharker
M. Bloomston
P. S. Wang
F. S. Chou

Document Type

Journal Article

Publication Date

2007

Journal

Endocrine-Related Cancer

Volume

14

Issue

2

Inclusive Pages

305-315

APA Citation

Mody, M., Dharker, N., Bloomston, M., Wang, P., & Chou, F. (2007). Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202. Endocrine-Related Cancer, 14 (2). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_biochem_facpubs/808